23
Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant.
 an acromegalic patient: Subject; hepatitis: Effect; combined treatment with pegvisomant and octreotide long-acting repeatable: Treatment; acromegalic: Treatment.Disorder; pegvisomant: Treatment.Drug; octreotide: Treatment.Drug; pegvisomant: Combination.Drug; octreotide: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 an acromegalic patient: Subject; hepatitis: Effect; combined treatment with pegvisomant and octreotide long-acting repeatable: Treatment; acromegalic: Treatment.Disorder; pegvisomant: Treatment.Drug; octreotide: Treatment.Drug; pegvisomant: Combination.Drug; octreotide: Combination.Drug